Vivos Therapeutics Inc (VVOS NASDAQ) stock market data APIs
$3.4856
-0.11(-3.2%)
as of September 17, 2025
Try our APIs with
free plan!
Vivos Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.
Prev. Close
3.4856
Open
3.3761
High
3.6632
Low
3.1813
52 wk Range
1.98-7.95
Market Cap
26 417 K
Shares Outstanding
7 505 K
Revenue
14 393 K
EPS
-0.55
Beta
6.986
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Vivos Therapeutics Inc data using free add-ons & libraries
Get Vivos Therapeutics Inc Fundamental Data
Vivos Therapeutics Inc Fundamental data includes:
- Net Revenue: 14 393 K
- EBITDA: -13 459 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-19
- EPS/Forecast: -0.39
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Vivos Therapeutics Inc News
New
Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment
LITTLETON, Colo., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc.(“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and technology company specializing in the...
Vivos Therapeutics GAAP EPS of -$0.55, revenue of $3.82M
* Vivos Therapeutics press release [https://seekingalpha.com/pr/20205846-vivos-therapeutics-reports-second-quarter-2025-financial-results-and-provides-operational] (NASDAQ:VVOS [https://seekingalpha...
Vivos Therapeutics Unveils New Model
Vivos Therapeutics(NASDAQ:VVOS) reported second quarter 2025 results on August 20, 2025, marking a pivotal shift from its legacy dentist-focused model to a direct, patient-centric sleep center strateg...
Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update
Quarter highlighted by the key acquisition of The Sleep Center of Nevada, which is generating revenue and seeing strong patient demand for Vivos’ differentiated array of highly effective OSA treatme...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
